• 28S rRNA Expansion Segments Build Nucleolar Layers

  2026-09-29

  Wei and colleagues show that 28S rRNA expansion segments act as multivalent architectural elements that can drive the formation of multilayered nucleolar-like structures. Their cross-species deletion and transfer experiments connect evolutionary RNA expansion with nucleolar complexity and provide a framework for studying RNA-mediated compartment organization.

• BMS-345541 Hydrochloride: IKK Inhibition Workflows

  2026-09-29

  BMS-345541 hydrochloride provides a selective way to interrogate IKK-1/IKK-2 control of NF-κB signaling, inflammatory cytokines, and cell fate. This practical guide connects dose planning and assay controls with inflammation research, T-ALL studies, and RIPK1-centered apoptosis or necroptosis experiments.

• Ivermectin: From Parasite Biology to Translation

  2026-09-28

  A mechanistic and strategic guide to using Ivermectin in translational parasitology, with lessons from Gasdermin C biology in pancreatic cancer for separating phenotype, mechanism, and therapeutic opportunity.

• How Inhibitors Promote p38α Dephosphorylation

  2026-09-28

  A bioRxiv study reports that some active-site inhibitors do more than block p38α MAP kinase: they shift its activation loop into a conformation that makes a phospho-threonine more accessible to the phosphatase WIP1. Biochemical and structural findings suggest a conformational route to kinase inhibition, while leaving cellular efficacy, selectivity, and disease relevance to be tested.

• Choosing Keratinocyte Models for NLRP1 Inflammasome Studies

  2026-09-27

  Wang, Yazdi, and Panayotova-Dimitrova compared primary keratinocytes with three immortalized lines to test how reliably each model reports NLRP1 inflammasome activation. UVB and talabostat induced cell death, but clear NLRP1 activation was detected in primary cells rather than the immortalized lines, supporting careful model selection and orthogonal readouts.

• TGF-β, Sca-1, and Mammary Cell Plasticity

  2026-09-26

  The study links TGF-β signaling to Sca-1 expression and altered lineage plasticity in pre-neoplastic mammary epithelial cells, while distinguishing endogenous Smad2/3/4-dependent regulation from exogenous TGF-β-driven Sca-1 loss that does not require Smad2/3. Its findings make Sca-1 a context-sensitive state marker and highlight the need to separate marker switching from enrichment of tumor-initiating cells.

• AG-221 (Enasidenib) for IDH2 AML Assays

  2026-09-25

  A practical guide to using AG-221 (Enasidenib), SKU B7804, in IDH2-mutant AML experiments, with guidance on 2-hydroxyglutarate, differentiation, viability, and metabolic readouts. It connects product handling details with evidence on CD44-mediated metabolic adaptation while distinguishing documented data from workflow recommendations.

• Firefly Luciferase mRNA for LNP Delivery Assays

  2026-09-25

  Use Firefly Luciferase mRNA (ARCA, 5-moUTP) as a sensitive reporter to compare transfection and lipid nanoparticle delivery workflows—not as a substitute for a direct cell-viability measurement. A recent freeze–thaw study points to a practical formulation question: test whether cryoprotectant handling changes delivery, then quantify the result with a consistent luciferase readout.

• Hyperthermia and Cisplatin Activate Caspase-8

  2026-09-24

  A 2024 study reports that hyperthermia combined with cisplatin promotes K63-linked polyubiquitination and accumulation of caspase-8, strengthening apoptotic and pyroptotic cell-death responses. Its perturbation experiments support a role for caspase-8 and Cullin 3 in these effects, while leaving questions about treatment timing, model breadth, and in vivo relevance for future work.

• BMS-345541 Hydrochloride in Inflammation Models

  2026-09-24

  BMS-345541 hydrochloride is an IKK inhibitor for probing how NF-κB signaling shapes inflammatory responses. This article connects its use to airway-stent research and explains how to separate pathway effects from angiogenesis, fibrosis, and cell viability in experimental models.

• Butyrate Shapes Bovine Satellite Cell Myogenesis

  2026-09-23

  This study maps how sodium butyrate concentration affects bovine skeletal muscle satellite-cell proliferation, differentiation, apoptosis, and transcriptional state. Its dose-dependent findings identify 1 mM for 2 days as a study-specific treatment condition and point to energy-metabolism and signaling pathways for further investigation.

• NIH/3T3 Cells: Culture, Recovery, and QC

  2026-09-23

  NIH/3T3 Cells (BC1017) provide a cryopreserved, adherent mouse fibroblast starting population for controlled expansion, cell transfection studies, viral proliferation research, and oncogene research. This dossier-based guide covers recovery, culture, assay preparation, and quality control, while distinguishing product specifications from workflow recommendations and limiting unsupported conclusions about quantitative performance, viral permissiveness, or clinical use.

• SAG in Hedgehog Assay Design and Disease Models

  2026-09-22

  SAG is a selective Smoothened receptor agonist for dissecting Hedgehog pathway signaling from Patched relief through GLI transcription. This guide translates mechanistic evidence into better reporter assays, pathway-positioning experiments, developmental models, and disease-oriented study design.

• Midecamycin: Workflow and Resistance Insights

  2026-09-22

  Midecamycin combines ribosome-focused antibacterial activity with a practical model for studying macrolide inactivation. This guide translates its Gram-positive selectivity, solvent constraints, and glycosylation biology into reproducible assay workflows and troubleshooting decisions.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-09-21

  Angiotensin I/II (1-5), the Asp-Arg-Val-Tyr-Ile peptide fragment, provides a defined reagent for renin-angiotensin system research involving blood pressure regulation, renal physiology, and aldosterone release stimulation. This guide covers solvent selection, storage, controls, and troubleshooting; the peptide should not be generalized to unrelated signaling assays or used as evidence of clinical efficacy.

8659 records 1/578 page Next 12345 下5页 Last page